The Expression and Action of Decay-Accelerating Factor (CD55) in Human Malignancies and Cancer Therapy
Decay-accelerating factor (DAF, CD55) is physiologically acting as an inhibitor of the complement system, but is also broadly expressed in malignant tumours. Here DAF seems to exert different functions beyond its immunological role such as e.g. promotion of tumorigenesis, decrease of complement medi...
Saved in:
Main Authors: | Jan-Henrik Mikesch, Kathrin Schier, Antje Roetger, Ronald Simon, Horst Buerger, Burkhard Brandt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2006-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.1155/2006/814816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recovering Decay Rates from Noisy Measurements with Maximum Entropy in the Mean
by: Henryk Gzyl, et al.
Published: (2009-01-01) -
The plot in Isaiah 40-55
by: SL Stassen
Published: (1997-12-01) -
The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?
by: Kathrin Maly, et al.
Published: (2015-01-01) -
Corrigendum to “The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?”
by: Kathrin Maly, et al.
Published: (2015-01-01) -
The generation and evaluation of TKO/hCD55/hTM/hEPCR gene-modified pigs for clinical organ xenotransplantation
by: Guoli Huai, et al.
Published: (2025-01-01)